Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $1.5 billion.

  • Dr Reddys Laboratories' Total Current Liabilities rose 32.55% to $1.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.5 billion, marking a year-over-year increase of 32.55%. This contributed to the annual value of $1.5 billion for FY2025, which is 32.55% up from last year.
  • As of FY2025, Dr Reddys Laboratories' Total Current Liabilities stood at $1.5 billion, which was up 32.55% from $1.2 billion recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Total Current Liabilities ranged from a high of $1.5 billion in FY2025 and a low of $1.0 billion during FY2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $1.2 billion (2024), whereas its average is $1.2 billion.
  • Per our database at Business Quant, Dr Reddys Laboratories' Total Current Liabilities declined by 15.74% in 2023 and then surged by 32.55% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Total Current Liabilities (Yearly) stood at $1.1 billion in 2021, then increased by 8.68% to $1.2 billion in 2022, then decreased by 15.74% to $1.0 billion in 2023, then grew by 10.34% to $1.2 billion in 2024, then surged by 32.55% to $1.5 billion in 2025.